Rockefeller Capital Management’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
Other funds holding AVXL
Rockefeller Capital Management's AVXL Position: Q3 2026 in Review
Rockefeller Capital Management reduced its Anavex Life Sciences (AVXL) stake by 0.86% in Q3 2026, selling an estimated $315 and leaving 13,098 shares worth $26.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3777.
Rockefeller Capital Management first reported a position in AVXL in Q1 2021 and has held it in 13 quarters since. The position peaked at $65.9K in Q3 2025. 165 funds tracked by Wall St. Rank hold AVXL as of Q3 2026.
- Rockefeller Capital Management held 13,098 shares of Anavex Life Sciences worth $26.5K as of Q3 2026.
- Rockefeller Capital Management sold 114 Anavex Life Sciences shares in Q3 2026, an estimated $315.
- Anavex Life Sciences made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q3 2026, its #3777 holding.
- Rockefeller Capital Management first reported a position in Anavex Life Sciences in Q1 2021 and has held it in 13 quarters since.
- Rockefeller Capital Management's Anavex Life Sciences position peaked at $65.9K in Q3 2025.
- 165 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2026.
Based on Rockefeller Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.